Outsourcing-Pharma Podcast
William Reed Ltd
Add to My Podcasts
Episodes
About
Reviews
Promote
Cobra Biologics talks recent fill finish acquisition and future growth plans
3 minutes
Posted Oct 24, 2012 at 11:00 pm.
0:00
3:46
Add to My Queue
Download
MP3
Share
episode
Share at current time
Show notes
CMO Cobra Biologics says North America is an obvious place to look at for a facility acquisition.
Previous
Catalent says sharing with industry will not dull competetive edge
Next
Optimism is returning to the pharma fine chemicals sector, says analyst
← See all 120 episodes of Outsourcing-Pharma Podcast
